This contract expires in 303 days (Jul 12, 2027).

Browse related active opportunities

NO SET ASIDE USED.

VERSAR, INC. - CONSULTATION AND PEER REVIEW FOR THE DIVISION OF RISK ASSESSMENT AND PRIORITIZATION

PIID: 75F40126C00062
Signed Date: Jul 14, 2026Effective Date: Jul 13, 2026End Date: Closes in 303 days
Award $
$694K
Vendor
VERSAR, INC.
NAICS
541690
Signed Date
Jul 14, 2026

Key Details

Dollars Obligated
$693,827.74
Base & All Options
$693,827.74
Awarding Sub-Agency
Food and Drug Administration
Product Service Code
B529 - SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
2
Place of Performance
SILVER SPRING, MD

Description

CONSULTATION AND PEER REVIEW FOR THE DIVISION OF RISK ASSESSMENT AND PRIORITIZATION

Context & Analysis

On Jul 14, 2026, Department of Health and Human Services obligated $693,827.74 to VERSAR, INC. for consultation and peer review for the division of risk assessment and prioritization. The award is classified under NAICS 541690 — OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES. Competition extent: full and open competition with 2 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in SILVER SPRING, MD. The contract is scheduled through Jul 12, 2027 — approximately 10 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541690 — related awards are listed below.

Contractor Information

Contractor: VERSAR, INC.
UEI: KTERFRZBVP66
Location: WASHINGTON, DC
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related